These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 23672350

  • 1. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.
    Yoon JH, Kim HJ, Shin SH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Lim JH.
    Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350
    [Abstract] [Full Text] [Related]

  • 2. Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia.
    Yoon JH, Kim HJ, Shin SH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Lim JH.
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):958-66. PubMed ID: 23542687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Correlation between clinical outcome and WT1 detection after hematopoietic stem cell transplantation in acute leukemia].
    Zhao BR, Tang XW, Cen JN, Jin S, Shi XL, Wei XA, Chang WR, Sun AN, Wu DP.
    Zhonghua Yi Xue Za Zhi; 2011 May 31; 91(20):1375-8. PubMed ID: 21756806
    [Abstract] [Full Text] [Related]

  • 9. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z, Leqing C, Yazhen Q, Yu W, Xiaohui Z, Lanping X, Xiaojun H, Yingjun C.
    Ann Hematol; 2019 Jan 31; 98(1):73-81. PubMed ID: 30159599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M, Palasek I, Pospisil Z, Borsky M, Klabusay M, Brychtova Y, Jurcek T, Jeziskova I, Krejci M, Dvorakova D, Mayer J.
    Exp Hematol; 2009 Jun 31; 37(6):659-72. PubMed ID: 19463768
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML.
    Nomdedéu JF, Hoyos M, Carricondo M, Bussaglia E, Estivill C, Esteve J, Tormo M, Duarte R, Salamero O, de Llano MP, García A, Bargay J, Heras I, Martí-Tutusaus JM, Llorente A, Ribera JM, Gallardo D, Aventin A, Brunet S, Sierra J, CETLAM Group.
    Leukemia; 2013 Nov 31; 27(11):2157-64. PubMed ID: 23584566
    [Abstract] [Full Text] [Related]

  • 17. Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression.
    Pozzi S, Geroldi S, Tedone E, Luchetti S, Grasso R, Colombo N, Di Grazia C, Lamparelli T, Gualandi F, Ibatici A, Bregante S, Van Lint MT, Raiola AM, Dominietto A, Varaldo R, Signori A, Bacigalupo A.
    Br J Haematol; 2013 Feb 31; 160(4):503-9. PubMed ID: 23294252
    [Abstract] [Full Text] [Related]

  • 18. Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia - a useful tool for early detection of minimal residual disease.
    Polak J, Hajkova H, Haskovec C, Cechova H, Marinov I, Mikulenkova D, Markova J, Markova M, Vitek A, Valkova V.
    Neoplasma; 2013 Feb 31; 60(1):74-82. PubMed ID: 23067220
    [Abstract] [Full Text] [Related]

  • 19. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
    Kim HJ, Choi EJ, Sohn HJ, Park SH, Min WS, Kim TG.
    Eur J Haematol; 2013 Nov 31; 91(5):411-22. PubMed ID: 23826993
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
    Kwon M, Martínez-Laperche C, Infante M, Carretero F, Balsalobre P, Serrano D, Gayoso J, Pérez-Corral A, Anguita J, Díez-Martín JL, Buño I.
    Biol Blood Marrow Transplant; 2012 Aug 31; 18(8):1235-42. PubMed ID: 22281301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.